ga('send', 'pageview');

Onglyza® Lawsuit Settlement Claims for Heart Failure

By March 13, 2018Onglyza

Did you or a loved one suffer from heart diseases after taking Onglyza®? Was anyone of your knowledge, who was prescribed this drug to get rid of type 2 diabetes and has died from cardiac arrest, end-organ failure or congestive heart failure? If yes, the injured party may be eligible or financial compensation.  Injury Help Desk has a network of attorneys that can file an Onglyza® lawsuit settlement claim for heart failure.

Injury Help Desk, a marketing agency that has connected 1000s of victims to top-tier legal representation (including the Los Angeles area), is dedicated to connecting you to the right lawyer for filing your Onglyza® lawsuit claims. Recent studies have shown that Onglyza® includes serious potential health risks that might cause serious injury or even death.

Several Onglyza® Lawsuit Claims have been filed against AstraZeneca, the manufacturer of Onglyza®. Most of the cases claimed that AstraZeneca had failed to warn the patients about the risks of taking Onglyza®(and the drug had caused fatal injuries or death. One lawsuit, filed by Rochelle Gibson, alleged that the drug had caused the death of Lillie Ree Gibson who took Onglyza® for a long period of time and died as the consequence of it. In the lawsuit, it was claimed that Lillie Ree Gibson died from cardiac failure after taking Onglyza®.

Type-2-diabetes is a difficult health condition which increases the risk of developing many deadly diseases and conditions like cardiac arrest, heart failure, congestive heart failure, cardiac failure and other ailments. However, type-2-diabetes is easily manageable with the correct medication. A step by step treatment method with the right medications helps the patients reduce or in some cases eliminate this health hazard and avoid cardiovascular complications. However, when diabetes patients begin using a certain medication, they don’t consider that the drug can potentially increase certain health risks.

The FDA approved Saxagliptin (the trade name for Onglyza® with the brand name Onglyza® in July 2009. On February 11, 2014, FDA originally issued a Drug Safety Communication for clinical trial and requested to find a link between this type 2 diabetes drug and heart failure. The clinical trial data found a link between these two.

Make sure to consult your doctor before starting or stopping any prescribed medications.


Author pawan

More posts by pawan

Leave a Reply